Andrea Seale's lobbying: the registrations they file and every meeting they've reported since November 2021.
← LobbyingRegistrant (responsible officer)
Chief Executive Officer
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Food and Drugs Act and regulations, as it relates to alcohol warning labels
Financial supports for caregivers, including the Canada Caregiver Credit
Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Financial supports for caregivers, including the Canada Caregiver Credit
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Access to information and support to make decisions regarding end-of-life care, including Medical Assistance In Dying
Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines
Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer.
Food and Drugs Act and regulations, as it relates to alcohol warning labels
Communication regarding alcohol consumption guidance.
Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines
Federal Tobacco Control Strategy, including all matters related to tobacco control
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer.
Sustained core funding for federal research agencies, improved coverage of indirect research costs, Canadian research sovereignty, strengthening capacity and the economic benefits of domestic research, research commercialization.
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer.
Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Issues related to health and cancer data including the priorities of the pan-Canadian Cancer Data Strategy, data governance and stewardship, how health data is collected, linked and used, addressing gaps in health data, health data interoperability, data issues related to health care system planning, cancer registries, benchmarks and reporting.
Increasing access to care including models of care, removing barriers to care, particularly for underserved communities, using innovative approaches to improve access to care including AI to improve timely diagnosis and treatment.
Financial supports for caregivers, including the Canada Caregiver Credit
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer.
Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement
Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement
Federal Tobacco Control Strategy, including all matters related to tobacco control
National Caregiving Strategy
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Food and Drugs Act and regulations, as it relates to alcohol warning labels
Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines
Financial supports for caregivers, including the Canada Caregiver Credit
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer.
Federal Tobacco Control Strategy, including all matters related to tobacco control
Food and Drugs Act and regulations, as it relates to nciotine replacement products
Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines
Financial supports for caregivers, including the Canada Caregiver Credit
Approvals process for the launch of clinical trials in Canada including regulation, funding, the creation of intellectual property and commercialization in Canada for the purpose of pharmaceutical sovereignty, economic development and scientific innovation.
Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people
Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.